Quantcast

Latest Healthcare in India Stories

2010-05-10 07:00:00

SAN DIEGO, May 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, May 17, 2010, at 11:05 a.m. local time (6:05 a.m. Eastern time), in the Albemarle Suite at the Grosvenor House Hotel in London. Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web...

2010-05-07 06:30:00

CALGARY, May 7 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2010 Annual and Special Meeting of the Shareholders will be held on Tuesday, May 11, 2010 at 4:30 p.m. Eastern Time at the Hilton Toronto Hotel, 145 Richmond Street West, Toronto, Ontario. Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN(R) as a potential cancer...

2010-05-05 16:22:00

CAMBRIDGE, Mass., May 5 /PRNewswire/ -- Abt Associates announced today the sale of its wholly-owned subsidiary Abt Bio-Pharma Solutions, Inc. (ABS) to United BioSource Corporation (UBC), a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies. The addition of ABS scientists and resources establishes UBC with the largest presence and operational reach...

2010-05-03 09:11:00

SAN FRANCISCO, May 3 /PRNewswire/ -- Despite the pop in the shares of Dendreon on the announcement that its prostate cancer therapy Provenge had finally been approved by the FDA, the biotech sector failed to build on that event and turned in a lackluster performance for the month with the Burrill Biotech Select Index dropping 2 percent in April. Not helping the cause was the fact that several companies including Amgen and Gilead Sciences cut their profit forecasts citing the impact of costs...

2010-04-29 07:00:00

LEWISBERRY, Pa., April 29 /PRNewswire-FirstCall/ -- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS; ASX: UNS), a leading developer of safety medical devices, today announced its entry into the Indian market to help support efforts by the Central Government of India and international agencies to institute the mandatory use of safety syringes within local healthcare facilities. Dr. Gerald Verollet, Vice-President of Scientific and International Affairs, has relocated to India...

2010-04-13 08:00:00

ST. LOUIS, April 13 /PRNewswire-FirstCall/ -- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company") today announced it has appointed Stephen A. Stamp as Chief Financial Officer and Treasurer, effective April 7, 2010. Mr. Stamp will report directly to David Van Vliet, interim CEO of the Company. David Van Vliet, interim CEO of the Company stated, "Stephen brings decades of financial experience and deep healthcare industry knowledge to K-V and we are excited to welcome him aboard. We...

2010-04-06 08:00:00

SAN FRANCISCO, April 6, 2010 /PRNewswire/ -- Germany is ranked number one in exporting research-intensive goods. This level of innovation drives the world's second largest market for biotechnology after the United States. Germany Trade & Invest will have representatives at this year's BayBio 2010 conference on April 7 in San Francisco, California, to highlight opportunities for American companies in Germany. There are more companies operating in the biotech and biomedical...

2010-04-06 06:30:00

CALGARY, April 6 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), is scheduled to present a corporate overview of the Company at BioFinance 2010 on Wednesday, April 7, 2010 at 10:30 a.m. (ET). The conference will be held at the Toronto Marriott Eaton Centre on April 6-8, 2010. About BioFinance 2010 BioFinance 2010 is the leading investor conference in Canada for the life sciences industry. This three-day event brings together...

2010-04-01 17:46:00

SAN FRANCISCO, April 1 /PRNewswire/ -- Biotech racked up impressive gains for both the month of March and the first quarter of 2010. The Burrill Biotech Select Index posted a 3.7 percent jump in value in March and an 8 percent overall gain for Q1 '10. The Dow also performed well in March, closing up 5.5 percent (4.5 percent for Q1 '10) with the NASDAQ doing even better - up 7 percent (5.7 percent for Q1 '10). "Biotechs certainly benefitted from the robust general markets this quarter,"...

2010-03-30 15:05:00

CAMBRIDGE, Mass., March 30 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has appointed Tamar D. Howson to its Board of Directors. Ms. Howson is currently a Partner at JSB-Partners, a transaction advisory firm serving the life sciences industry. Ms. Howson has extensive experience in licensing, collaborations and M&A...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related